Kaia Health Unveils Complete Musculoskeletal Care Solution with Kaia Gateway and Premium Partners

February 10, 2021

Kaia Health

Kaia Health, announces Kaia Gateway and Premium Partners, the next-generation complete MSK care solution for all U.S. employers and health plans, based on the industry’s largest randomized controlled trial (RCT), which showed how a treatment path, combining digital therapy, personalized health coaching and a collaboration with medical providers, achieved better outcomes than standard of care.

Kaia Health’s digital MSK program has already treated 450,000 patients to date. Their complete MSK care solution will feature a rigorous claims-based ROI for each client and support preventative, acute, chronic and presurgical care for total spine, hip, knee, shoulder, hand, wrist, foot, and ankle. These capabilities will be fully rolled out by January 2022.

Kaia Health

 

 

 

 

Introducing the all-new Kaia Gateway

Kaia Gateway is the new front door for all MSK patients and accessed via Kaia Health’s existing digital MSK program.

A clinical triage algorithm will screen each patient and direct those at risk of needing more invasive or intense treatment to a Kaia Health medical provider for case review. An AI-enabled escalation algorithm will monitor patients longitudinally for clinical and behavioral patterns, mitigating the risk of unnecessary elective, and often costly, surgery.

The algorithms feature Kaia Health’s patented Motion Coach™ computer vision technology, which, using a smartphone, tracks thousands of data points on a patient’s body and provides real-time exercise feedback. This creates a more personalized, engaging experience than sensor straps or periodic video chats.

“Kaia Gateway creates an unprecedented level of understanding of MSK patients and their progression,” says Justin Yang, Kaia Health’s U.S. Chief Medical Officer. “The algorithms now include Motion Coach™ data in addition to self-reported and adherence data. Motion Coach™ thus now drives our clinical decision making in addition to patient engagement. This richer dataset will offer a more informed user case review and allow Kaia Gateway to make better patient choices in the treatment app or via one of our partners.”

Introducing Premium Partners

Today, Kaia Health coaches refer out to other medical services within employers’ ecosystems. Premium Partners represent a deeper level of partner integration. They will be closely tied to Kaia’s existing MSK treatment and have access to detailed treatment history, including Motion Coach™ insights and disease progression. It will also feature other care solutions, including digital interventions, PT and telemedicine.

In a recent regional health system deployment, Kaia Health’s MSK app use resulted in a 22% medical claims net cost savings and 50% decrease in MSK pain level. For employers, Kaia Health’s MSK app has demonstrated more than 20% decrease in medical spend with a 1.6x – 3x average ROI in the first year.

MSK conditions affect 126.6 million Americans, which result in annual costs to U.S. employers of $120 billion. MSK costs business an average of $425 per member per year in medical bills, affects 25% of their workforce and accounts for 16% of overall medical spend.

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.